Stealth BioTherapeutics Corp (MITO)

[INFINITI]

Stealth Biotherapeutics (MITO) Gets a Buy Rating from Maxim Group

Source: TipRanks
Maxim Group analyst Jason McCarthy maintained a Buy rating on Stealth Biotherapeutics (MITO – Research Report) yesterday and set a price target of $1.00. The company's shares closed last Friday at $0.19. According to TipRanks.com, McCarthy has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -36.9% and a 11.6% success rate. McCarthy covers the Healthcare sector, focusing on stocks such as Brainstorm Cell Therapeutics, Brooklyn ImmunoTherapeutics, and SELLAS Life Sciences Group. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Stealth Biotherapeutics with a $2.50 average price target.